1.An overview of the evolution of EV71 vaccine.
Journal of Biomedical Engineering 2010;27(4):933-936
EV71 infection has become a serious public health threat especially among young children. Yet, at present, no specific antiviral drug against EV71 infection is available. A number of scientists are studying various kinds of vaccines, including inactivated vaccine, virus-like particle vaccine, DNA vaccine, synthetic peptide vaccines, and transgenic oral vaccine. This article reviews the recent advancement in the design of various kinds of vaccine against EV71 as well as their prospective usefulness, effectiveness, weakness and developments in the foreground.
Enterovirus A, Human
;
immunology
;
Hand, Foot and Mouth Disease
;
immunology
;
prevention & control
;
Humans
;
Vaccines, Attenuated
;
immunology
;
Vaccines, DNA
;
immunology
;
Vaccines, Inactivated
;
immunology
;
Vaccines, Synthetic
;
immunology
;
Viral Vaccines
;
immunology
2.Development of tumor vaccine on gynecologic cancer.
Acta Academiae Medicinae Sinicae 2003;25(4):487-491
The study of tumor vaccine is one of the focus of immunological therapy on malignant gynecologic cancer. All of the ovarian carcinoma vaccine are therapeutic, including cloned antigen vaccine, tumor cell vaccine, genetic engineering tumor cell vaccine, dendritic cell (DC) vaccine, as well as anti-idiotypic vaccine. The therapeutic vaccines based on human papillomavirus (HPV) of cervical cancer are mostly summarized, including polypeptides vaccine, carrier vaccine, fusion protein or chimeric vaccine, and DC vaccine. The preventive vaccine based on HPV of cervical cancer are briefly introduced. As there are only a few reports on endometrial carcinoma vaccine.
Cancer Vaccines
;
biosynthesis
;
immunology
;
Dendritic Cells
;
immunology
;
Female
;
Genetic Engineering
;
Humans
;
Ovarian Neoplasms
;
immunology
;
Papillomaviridae
;
immunology
;
Papillomavirus Infections
;
immunology
;
Uterine Cervical Neoplasms
;
immunology
;
Vaccines, DNA
;
immunology
3.SSB peptide and DNA co-immunization induces inhibition of anti-dsDNA antibody production in rabbits.
Chinese Medical Journal 2008;121(3):227-230
BACKGROUNDPatients with systemic lupus erythematosus often have various autoantibodies. The relationship between these antibodies is still poorly understood. The aim of the present study was to observe the anti-SSB antibody and anti-dsDNA antibody production profiles following immunization with synthetic SSB peptide alone, DNA alone or co-immunization with these two antigens.
METHODSSSB 214 - 225 aa peptide was synthesized by organic chemistry solid-phase peptide synthesis. Rabbits were immunized with the following antigens: synthetic SSB peptide linked with keyhole limpet hemocyanin (KLH), DNA, SSB plus dsDNA, KLH and PBS. Antibodies were measured by ELISA. Histopathology and direct immufluorescence assays were also applied.
RESULTSAnti-SSB and anti-dsDNA antibodies were produced following immunization with SSB peptide and DNA respectively. The level of SSB antibody in the co-immunization group was higher than that of the SSB peptide immunization group. The level of anti-dsDNA antibody in the co-immunization group was, however, lower than that in the DNA immunization group. Meanwhile, the level of anti-SSB antibody was higher than that of anti-DNA antibody in the co-immunization group. No morphological or immunological abnormalities were found in the heart, liver, kidney, spleen or skin tissues.
CONCLUSIONInhibition of anti-dsDNA-antibody was induced by co-immunization with synthesized SSB peptide and DNA, which might explain, at least partly, the mild disease in some LE subsets associated with SSB antibody.
Animals ; Antibodies, Antinuclear ; biosynthesis ; Autoantigens ; immunology ; DNA ; immunology ; Fluorescent Antibody Technique, Direct ; Immunization ; Rabbits ; Ribonucleoproteins ; immunology
4.Multi-epitope DNA vaccines against avian influenza in chickens.
Jin-Mei PENG ; Guang-Zhi TONG ; Yun-Feng WANG ; Hua-Ji QIU
Chinese Journal of Biotechnology 2003;19(5):623-627
Multiple epitopes from one or more viruses can be lined up and co-expressed in one vector to generate multi-epitopes DNA vaccines. In the study, four recombinant plasmids were constructed based on HA and NP gene of avian influenza virus (AIV) (H5N1): (1) pIRES/HA, carrying the complete HA gene; (2) pIRES/tHA, carrying a truncated HA gene fragment of major neutralizing antigenic epitopes; (3) pIRES/tHA-NPep, in which three CTL epitopes of NP gene of AIV were fused to the truncated HA from the C-terminal; and (4) pIRES/tHA-NPep-IFN-gamma, which was constructed by replacing neo gene in pIRES/ tHA-NPep with IFN-y of chicken. Fifty five SPF chickens were randomly divided into five groups and immunized with the above four constructs and control plasmid. Each chicken was intramuscally immunized with 200 microg plasmid DNA three times in a two-week interval. Two weeks after the third immunization, chickens were injected with H5N1 subtype avian influenza virus. Before the virus loading no detectable antibodies to HA were found in the chicken serum; but high levels of HI antibodies were detected in the serum of the survived chickens. The percentages of CD4+ and CD8+ T lymphocyte in peripheral blood of immunized chickens increased steadily after the vaccination. After virus loading all chickens in the control group died within three to eight days, and the survival rates of the four DNA vaccine groups were as follows: pIRES/HA, 54.5%; pIRES/tHA, 30%, pIRES/ tHA-NPep, 36.3%, pIRES/tHA-NPep-IFN-gamma, 50%. These results indicated that multi-epitopes DNA immunization can induce immune response and protect chickens from homologous virus loading.
Animals
;
Chickens
;
Epitopes
;
immunology
;
Influenza A Virus, H5N1 Subtype
;
immunology
;
pathogenicity
;
Influenza in Birds
;
immunology
;
prevention & control
;
virology
;
Vaccines, DNA
;
immunology
5.Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization.
Journal of Biomedical Engineering 2003;20(1):175-179
DNA vaccination that can induce both cellular and humoral immune response has become an attractive immunization strategy against cancer and infectious disease. Elucidation of the precise mechanisms of immune priming will be important in the development of effective DNA vaccines. In this review, we illustrate possible mechanisms in priming cytotoxic T cell response involving the intracellular degradation, processing and presentation of encoded antigen. We also discuss the roles of costimulatory molecules expressed on antigen-presenting cells (APCs) in inducing optimal CTL activity. Hence, a rational strategy for increasing DNA potency would be to facilitate these pathways. Additionally, we focus on recent strategies including rapid degradation of ubiquitin-antigen fusion proteins, direct targeting to APCs for increased DNA uptake, direct routing an antigen into the MHC class I and II processing and presentation pathways, and increasing the immunogenicity of encoded antigen. All of these approaches have resulted in increased potency of DNA vaccines.
Animals
;
Antigen Presentation
;
Antigen-Presenting Cells
;
immunology
;
Lysosomes
;
immunology
;
Mice
;
T-Lymphocytes, Cytotoxic
;
immunology
;
Ubiquitin
;
physiology
;
Vaccines, DNA
;
genetics
;
immunology
6.Progress in research on molecular biology and application in dominant antigens ESAT6 and CFP10 of TB vaccine.
Journal of Biomedical Engineering 2012;29(2):392-396
As the dominant antigens, early secreted antigenic target 6 (ESAT6, E6) and culture filtrate protein 10 (CFP10, C10) had once been the focus of tuberculosis (TB) vaccine due to their capability of inducing strong cell immune response in the host. They are also endowed with promising future of prevention against and diagnosis of TB. In this review, we systematically introduce recent research progress of E6 and C10, especially in structure-function, biological characteristics, protein expression and secretion, host immunity and vaccine development, and the prospects of their application are also discussed.
Antigens, Bacterial
;
chemistry
;
genetics
;
immunology
;
Bacterial Proteins
;
chemistry
;
genetics
;
immunology
;
Humans
;
Immunodominant Epitopes
;
immunology
;
Molecular Biology
;
Peptide Fragments
;
chemistry
;
genetics
;
immunology
;
Tuberculosis Vaccines
;
genetics
;
immunology
;
Vaccines, DNA
;
immunology
7.Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein.
Qingtao WANG ; Yuhai CHEN ; Shijuan GAO ; Wei JIANG ; Liping SONG ; Wenlin HUANG
Chinese Journal of Biotechnology 2011;27(5):773-780
New strategies to improve vaccine efficacy against human immunodeficiency virus type 1 (HIV-1) are still required. DNA vaccines, exhibiting potential advantages over conventional vaccines for their simplicity and versatility, can induce specific humoral and cellular immune responses. We developed a recombinant pVAX1 DNA vector carrying p24 gene of HIV-1. The results showed that pVAX1 mediated gene possessed the ability of effective expression in both transfected 293T cells and BALB/c mice. And pVAX1-p24 DNA prime and boost immunization can induce significant P24-specific humoral immune responses and cellular immune responses in BALB/c mice. Furthermore, immunization with pVAX1-p24 DNA prime and protein boost induced 7.3 to 8.0-fold greater p24-specific humoral responses than pVAX1-p24 DNA prime and boost, while the cellular immune responses induced by combined immunization was lower. The results suggested that pVAX1-p24 DNA and P24 protein vaccine is a promising HIV-1 vaccine, and the selections of the immunization strategies are important for the immunization results.
AIDS Vaccines
;
genetics
;
immunology
;
Animals
;
DNA
;
genetics
;
immunology
;
HEK293 Cells
;
HIV Core Protein p24
;
genetics
;
immunology
;
Humans
;
Immunization
;
Mice
;
Mice, Inbred BALB C
;
Vaccines, DNA
;
genetics
;
immunology
8.Construction of the DNA vaccine of major outer membrane protein of Neisseria gonorrhoeae and investigation of immune effects after vaccination.
Fang LIAO ; Chao HE ; Hai-Peng LIU ; Qi-Fa SONG ; Jie YAN
Chinese Journal of Preventive Medicine 2006;40(6):422-426
OBJECTIVETo clone PIB gene of Neisseria gonorrhoeae, and to construct a recombinant eukaryotic expression vector pCI-PIB and to understand the effects of pCI-PIB vaccination in mice to induce specific humoral and cellular immune responses.
METHODSThe entire PIB gene of Neisseria gonorrhoeae (960 bp) was amplified by using PCR. An eukaryotic eukaryotic vector pCI-PIB was then constructed. BALB/c mice (n = 65, 100 microg/time/mouse) were immunized with pCI-PIB by intramuscular injection. ABC assay was employed to examine the PIB expression in muscular cells of the pCI-PIB-immunized mice (n = 10). ELISA and MTT assays were used to measure the effects of humoral and cellular immune responses of the remaining pCI-PIB-immunized mice. By using slide agglutination test and complement bacteriolytic test, the serum anti-bacterial activity of the pCI-PIB immunized mice was determined.
RESULTSThe entire PIB gene amplification fragment of the expected size (960 bp) was successfully obtained by PCR. In comparison with the reported PIB gene sequence (GenBank No: AF090801), the homology of nucleotide sequence of the target inserted fragment in the recombinant plasmid pCI-PIB was as high as 99.28%. The muscular cells of the immunized mice could take in pCI-PIB and then express PIB. In the pCI-PIB immunized mice, the higher titer (1:4000) of specific serum IgG and the specific T lymphocyte response were found. The proliferation index (4.031) was significantly higher than that of the controls (1.127) (t = 71.71, P < 0.05). The sera and washings from the pCI-PIB immunized mice could agglutinate Neisseria gonorrhoeae and kill this microbe in presence of complements.
CONCLUSIONIn this study we successfully constructed a recombinant eukaryotic expression vector pCI-PIB. The mice inoculated with pCI-PIB might efficiently produce the specific humoral and cellular immune responses, suggesting that pCI-PIB should be potential service as a candidate of Neisseria gonorrhoeae DNA vaccines.
Animals ; Antibody Formation ; Bacterial Outer Membrane Proteins ; genetics ; immunology ; DNA, Recombinant ; immunology ; Female ; Immunity, Cellular ; Mice ; Mice, Inbred BALB C ; Neisseria gonorrhoeae ; genetics ; immunology ; Plasmids ; Vaccines, DNA ; immunology
9.Immuno-screening of Schistosoma japonicum cercariae cDNA library by the sera of anti-soluble cercariae 66 to approximately 68 kD antigens.
Yong-Hua QIN ; Shuai-Feng ZHOU ; Shi-Ping WANG
Journal of Central South University(Medical Sciences) 2008;33(12):1076-1081
OBJECTIVE:
To obtain the coding genes related to Schistosoma japonicum (Sj) cercariae 66 to approximately 68 kD antigens,and to provide antigens for diagnosis and vaccine of schistosomiasis.
METHODS:
Sj cercariae cDNA library was screened using the monospecific anti-sera of rabbit against soluble cercariae 66 to approximately 68 kD antigens as probes.The inserted cDNA fragments of the positive clones were amplified with PCR and identified by agarose gel electrophoresis. Four strong positive clones were further sequenced and analyzed through the internet NCBI/BLAST software.
RESULTS:
Twenty-one positive clones were obtained, 10 of which revealed a single band (0.5 to approximately 3.0 kb).The 4 strong positive clones showed high identity to SJCHGC05187,SJCHGC05173,SJCHGC06989, and SJCHGC01894 at the nucleotide level.
CONCLUSION
Four coding genes related with Sj antigens are obtained.
Animals
;
Antibodies, Helminth
;
immunology
;
Antigens, Helminth
;
immunology
;
Cercaria
;
genetics
;
immunology
;
DNA, Complementary
;
genetics
;
Gene Library
;
Immune Sera
;
immunology
;
Schistosoma japonicum
;
genetics
;
immunology
10.Foxp3(+)Treg cells mediate immune protection of Humulus pollen allergy DNA vaccine pcDNA3.1-Hum in asthmatic mice.
Jiamei LU ; Manxiang LI ; Xiuzhen SUN ; Yonghong ZHANG ; Yun LIU ; Jing XU ; Sumei ZHANG
Journal of Southern Medical University 2014;34(1):14-19
OBJECTIVETo construct a humulus pollen allergy DNA vaccine pcDNA3.1-Hum and investigate its effect for immune protection mediated by Foxp3(+)Treg cells in asthmatic mice.
METHODSThe target humulus gene obtained from pTripIEx2-Hum plasmid by double enzyme digestion was inserted sequentially into pcDNA3.1(-) vector to generate the recombinant plasmid pcDNA3.1-Hum, which was validated by sequencing. The pcDNA3.1-Hum plasmid was transfected into COS-7 cells and the expression of the ectopic protein was analyzed using Western blotting. Co-cultured dendritic cells and CD4(+)CD25(-) T cells were stimulated with the expressed protein to test its efficacy in inducing Foxp3(+)Treg cells. The levels of humulus-specific IgE and IgG2a were assayed to evaluate the allergenicity and immunogenicity of pcDNA3.1-Hum in mice. The immunoprotective effect of pcDNA3.1-Hum was assessed in a mouse model of humulus-specific asthma.
RESULTSThe constructed pcDNA3.1-Hum plasmid was validated by sequencing and Western blotting, and the expressed protein was shown to induce Foxp3(+)Treg cells in the co-culture. In normal mice, pcDNA3.1-Hum induced a significant increase of humulus-specific IgG2a but had no effect on IgE. In the asthmatic mice, pcDNA3.1-Hum significantly decreased inflammatory cell counts and eosinophil percentages in the BALF, ameliorated lung inflammation, and lowered AHR and IL-4 levels; immunization of the mice with pcDNA3.1-Hum reversed humulus-induced reduction of serum IFN-γ and prevented the humulus-triggered reduction of Foxp3(+)Treg cell percentage in the spleen.
CONCLUSIONWe have successfully constructed a highly immunogenic pcDNA3.1-Hum DNA vaccine that can mediate immune protection by inducing Foxp3(+)Treg cells.
Allergens ; immunology ; Animals ; Asthma ; immunology ; Cell Differentiation ; Disease Models, Animal ; Female ; Humulus ; immunology ; Mice ; Mice, Inbred BALB C ; Plasmids ; T-Lymphocytes, Regulatory ; cytology ; immunology ; Vaccines, DNA ; immunology